Enavatuzumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Enavatuzumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target TWEAK receptor
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
Formula C6334H9792N1700O2000S42
Molar mass 143.1 kg/mol
 NYesY (what is this?)  (verify)

Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors.

Enavatuzumab was developed by Facet Biotech Corp.[1]

References[edit]